FDA - Food and Drug Administration
Trump to expand prescription drug site with 600 cheaper generic medicines in push to lower costs
More than 600 generics will be available through the website, Trump said, part of an effort by the administration to expand access to lower-cost medicines.
Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy
RFK Jr.’s health department ordered withdrawal of studies showing vaccine efficiency - report
'Miracle cure': 2-year-old steals show at White House announcement of hearing loss therapy approval
Have breast implants? Israeli study warns they cause autoimmune, mental problems
Lack of FDA supervision, data on side effects hidden by companies resulted in severe autoimmune and mental complications * Permission in 1960s to allow the technology was a “historical medical error”
Israeli company SoniVie receives FDA approval for innovative hypertension treatment
SoniVie’s treatment is called TIVUS – an innovative Ultrasound system that treats Hypertension patients with Renal Artery Denervation.
US, Canada investigate Hepatitis A outbreak linked to strawberries
"Consumption of imported fresh organic strawberries is the likely source of the outbreak," American and Canadian health agencies said.
US FDA clears Pfizer's COVID booster shot for young children
Children below the age of five are not yet eligible for a COVID-19 vaccine in the United States.
State sues Teva over Copaxone drug royalties
Two doctors sued Teva for failing to acknowledge their contributions and demanded to be compensated with royalties stemming from the new version of copaxone.
BioGenCell raises $16m. for chronic disease treatment
The company’s treatment has already prevented loss of limb in several patients during Phase I trials.
Biogen pulls application for Alzheimer's drug in Europe
The drugmaker said the move follows interactions with the European Medicines Agency that suggested data provided so far would not be enough to support an approval.
Japan's Kowa says Ivermectin showed 'antiviral effect' against Omicron
Clinical trials are ongoing, but promotion of ivermectin as a COVID-19 treatment has generated controversy.
Biogen shares slide as Medicare restricts cover of Alzheimer's treatments
The coverage decision by US Centers for Medicare and Medicaid Services (CMS), the health agency that runs Medicare, crushes any hopes of the drug Aduhelm gaining traction.
Wait 3 days, then swab throat and nose when using antigen test, Health Ministry says
The Health Ministry published new recommendations on how to use the at-home kits, amid criticism for their lack of accuracy.
